Sheela Foam Q3 FY26: Revenue Up 11% to ₹1,074 Cr, Core EBITDA Jumps 39% to ₹117 Cr
Sheela Foam reported Q3 FY26 consolidated revenue of ₹1,074 crore, up 11% YoY. Core EBITDA surged 39% to ₹117 crore. For 9M FY26, consolidated revenue was ₹2,771 crore (up 7% YoY) and Core EBITDA rose 34% to ₹293 crore. Standalone revenue increased 8% to ₹842 crore in Q3 FY26, with Core EBITDA up 42% to ₹87 crore.
The announcement details strong financial results with double-digit growth in revenue and substantial increases in EBITDA, alongside positive operational highlights and international business performance, which are material factors for investors.
The company reported significant year-on-year growth in revenue and Core EBITDA for both the quarter and the nine-month period, indicating strong operational performance and improving profitability.
Sheela Foam Limited has announced its unaudited financial results for the quarter and nine-month period ended December 31, 2025. The company reported a consolidated revenue of ₹1,074 crore for Q3 FY26, an 11% increase year-on-year, and a 23% increase quarter-on-quarter from ₹875 crore in Q2 FY26.
Consolidated Core EBITDA for the quarter surged by 39% year-on-year to ₹117 crore, with the EBITDA margin improving to 10.9% from 8.7% in Q3 FY25. For the nine-month period ended December 31, 2025, consolidated revenue grew by 7% to ₹2,771 crore, while Core EBITDA increased by a significant 34% to ₹293 crore, with margins expanding by 2.1% to 10.6%.
On a standalone basis (SFL + KEL), Q3 FY26 revenue rose by 8% to ₹842 crore, and Core EBITDA increased by 42% to ₹87 crore, with margins improving by 2.5% to 10.3%. For the nine months of FY26, standalone revenue grew by 6% to ₹2,143 crore, and Core EBITDA rose by 33% to ₹224 crore, with margins improving by 2.1% to 10%.
The company highlighted strong volume growth in its mattress and foam segments. Key initiatives in mattresses and foam are driving volume growth, with e-commerce sales showing substantial growth. The company is also strengthening its unorganized to organized outreach across various channels and geographies. International operations in Australia (Joyce) and Spain (Interplasp) also showed improved performance with revenue growth and better EBITDA margins.
What to do with a filing like this
Sheela Foam Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sheela Foam Limited. Read the original for the full detail.